Saturday, March 15, 2025
5.4 C
London
HomeFinTechMekonos: Raises $4.6M in Funding

Mekonos: Raises $4.6M in Funding

Date:

ABN AMRO-Owned Neobroker Fined $1.6M for Paying Finfluencers

A Significant Penalty in the Financial Industry Highlights Regulatory...

AvidXchange Explores Potential Sale Amid Market Changes

What Investors Need to Know About AvidXchange's Strategic ShiftHighlights:...

Raisin Expands Its Offerings by Launching in Finland

Discover how Raisin is transforming the financial landscape in...
  • Mekonos, a San Francisco, CA-based biotech company launching a system-on-a-chip (SoC) for targeted ex vivo gene engineering, completed a $4.6m financing round
  • The round was led by Novartis AG with participation from institutional VCs including Hike Ventures, CRCM Ventures
  • The company will also use the new capital to accelerate the SoC platform for its current and new commercial partnerships
  • Led by Anil Narasimha, Ph.D., Co-Founder and CEO, Mekonos is a biotech company advancing a gene engineering platform SoC platform, with IP from Stanford University
  • The platform also helps companies increase capacity, accelerate discoveries, and develop new pre-clinical assets in the emerging cell and gene therapy space
  • Mekonos recently completed pilots with key top pharmaceutical companies and research institutes that demonstrated high efficacy of modified gene expression and cell viability

Related stories

spot_img

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Latest stories